Minor Use Minor Species Development of Drugs; Research Project Grant (R01)

The summary for the Minor Use Minor Species Development of Drugs; Research Project Grant (R01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, the government agency offering the grant, funding award amounts, and important deadlines. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section.

Federal Grant Title:	Minor Use Minor Species Development of Drugs; Research Project Grant (R01)
CFDA Number:	93.103
CFDA Description:	Food and Drug Administration_Research
Federal Agency Name:	Food Drug Administration
Category of Funding Activity:	Business and Commerce Consumer Protection Education Employment Labor and Training Health Housing Science and Technology
Category Explanation:	Information not provided
Opportunity Category:	Discretionary
Funding Opportunity Number:	RFA-FD-09-008
Document Type:	Grants Notice
Funding Instrument Type:	Grant
Posted Date:	May 22, 2009
Creation Date:	May 22, 2009
Original Closing Date for Applications:	Jul 01, 2009
Current Closing Date for Applications:	Jul 01, 2009
Archive Date:	Jul 31, 2009
Expected Number of Awards:	10
Estimated Total Program Funding:	$750,000
Federal Grant Award Ceiling:	$100,000
Federal Grant Award Floor:	$50,000
Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Hispanic-serving Institutions* Historically Black Colleges and Universities (HBCUs)* Tribally Controlled Colleges and Universities (TCCUs)* Alaska Native and Native Hawaiian Serving Institutions * For-Profit Organizations (Other than Small Businesses)* Indian/Native American Tribally Designated Organizations* U.S. Territory or Possession Indian/Native American Tribal Governments (Other than Federally Recognized)* Non-domestic (non-U.S.) Entities (Foreign Organizations) * Eligible Agencies of the Federal Government � Agencies that are part of HHS may not apply * Faith-based or Community-based Organizations
Grant Description: The Research Project Grant (R01) is an award to support a discrete, specified, circumscribed project to be performed by named Project Directors/Principal Investigators (PDs/PIs) in the areas representing the investigators' specific interest and competencies based on the mission of FDA. FDA Awards R01 grants to institutions/organizations of all types. This mechanism allows the PDs/PIs to define the scientific focus or objective of the research based on particular areas of interest and competence. Although the PDs/PIs write the grant application and are responsible for conducting and supervising the research, the actual applicant is the research institution/organization. The Office of Minor Use & Minor Species Animal Drug Development (OMUMS) was created to promote the development of drugs intended for minor use in major species of animals or for use in minor species of animals (MUMS drugs). Major species of animals are: horses, dogs, cats, cattle, pigs, turkeys, and chickens. All other animal species (except humans) are minor species. A minor use in a major species is one that involves use of a drug in no more than the following number of animals of a major species in the United States on an annual basis: Horses-50,000; Dogs-70,000; Cats-120,000; Cattle-310,000; Pigs-1,450,000; Turkeys-14,000,000; Chickens-72,000,000. Additional information about OMUMS is available on FDA's Website at www.fda.gov/cvm/minortoc.htm. The primary goal of FDA's OMUMS grant program is to support the development of drugs intended for minor use or intended for use in minor species. Only animal drugs that have qualified for designation in accordance with the provisions of 21 CFR Part 516 are eligible for grants. FDA is authorized to provide grants for designated new animal drugs to defray the costs of qualified safety and effectiveness testing, or expenses incurred in the development of processes and procedures associated with manufacture of a designated MUMS drug. However, this FOA only relates to grants to defray the costs of qualified safety and effectiveness testing when a grant will either result in, or substantially contribute to, approval or conditional approval of a designated MUMS drug. Applicants must include an explanation of how the proposed study will help gain product approval or conditional approval in the application's "Background and Significance" section. All funded studies are subject to the requirements of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 331 et seq.), regulations issued under it, and applicable Department of Health and Human Services (HHS) statutes and regulations.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-fd-09-008.html
Grant Announcement Contact: Marc Pitts Electron Research Administration Liaison Phone 301-827-7162 Marc.Pitts@FDA.HHS.GOV [Marc.Pitts@FDA.HHS.GOV]
Similar Government Grants: • Opportunity RFA-FD-10-001; • Convener of Active Medical Product Surveillance Discussions (U13); • Opportunity PAR-09-215; • Opportunity PAR-09-203; • Opportunity PA-09-183; • Support for Small Scientific Conference Grant Program; • Cooperative Agreement to Support the World Health Organization (WHO) International Programme on Chem...; • Clinical Studies of Safety and Effectiveness of Orphan Products; • FDA State Food Safety Task Force Conference; • Food Safety and Security Research - Rapid Methods Development